Adaptive Biotechnologies (ADPT) Current Leases (2020 - 2026)

Adaptive Biotechnologies (ADPT) has 7 years of Current Leases data on file, last reported at $8.5 million in Q1 2026.

• Quarterly Current Leases fell 18.63% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (down 18.63% YoY) and the FY2025 annual result came in at $8.9 million, down 12.88% from the prior year.
• Current Leases retreated to $8.5 million in Q1 2026 per ADPT's latest filing, from $8.9 million in the prior quarter.
• The five-year high for Current Leases was $10.5 million in Q1 2025, with the low at $8.5 million in Q1 2026.
• Average Current Leases over 5 years is $9.4 million, with a median of $9.4 million recorded in 2023.
• Year-over-year, Current Leases jumped 98.35% in 2022 and decreased 18.63% in 2026.
• Adaptive Biotechnologies' Current Leases stood at $9.2 million in 2022, then climbed by 1.67% to $9.4 million in 2023, then gained by 9.11% to $10.2 million in 2024, then dropped by 12.88% to $8.9 million in 2025, then retreated by 4.56% to $8.5 million in 2026.
• Business Quant data shows ADPT's Current Leases at $8.5 million in Q1 2026, $8.9 million in Q4 2025, and $9.4 million in Q3 2025.